LBT Innovations (ASX:LBT) Presentation, FNN Investor Event, September 2019, Sydney

Company Presentations

LBT Innovations Limited (ASX:LBT) Managing Director and CEO Brent Barnes presents on the company's FY19 results and outlook, including the adoption of its culture plate reading device APAS Independence, the sales process and regulatory approval, at FNN's Investor Event.

Key points:

  • Artificial intelligence platform automating manual healthcare processes
  • Commercial launch underway US, EU and AU
  • Attractive revenue model -- upfront + annual fees. 5-year revenue opportunity. Around US$0.45m per instrument.
  • 1st sale completed -- St Vincent’s Hospital, Melbourne
  • APAS® available for sale in Germany and United States in second half of CY 2019
  • Market cap around $23.5 million
  • Shareholders: Insto (7%), Industry (7%), Dir + Mgmt (4%)

For more, watch Managing Director and CEO Brent Barnes present.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.